AbbVie to present Phase 3 etentamig data at myeloma meeting

September 17, 2026 8:30 AM

AbbVie (NYSE: ABBV) announced it will present data from its multiple myeloma research portfolio at the 23rd International Myeloma Society ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found